Standardized semiquantitative analysis of corneal neovascularization using projected corneal photographs - Pilot study after perforating corneal keratoplasty before immune reaction;Standardisiertes beurteilungsschema zur semiquantitativen analyse der kornealen neovaskularisation mittels projizierter hornhautfotografien - Pilotstudie nach nicht-hochrisiko-keratoplastik vor anschließender immunreaktion

Klinische Monatsblatter fur Augenheilkunde

Volumn 218, Issue 7, 2001, Pages 484-491

  Cursiefen, C ^a   Wenkel, H ^a   Martus, P ^b   Langenbucher, A ^a   Seitz, B ^a   Kuchle M ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Corneal angiogenesis; Corneal transplantation; Immune reaction; Neovascularization; Quantification

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CORNEA NEOVASCULARIZATION; CORNEA TRANSPLANTATION; GRAFT REJECTION; HUMAN; IMMUNITY; PENETRATING KERATOPLASTY; PHOTOGRAPHY; PILOT STUDY; QUANTITATIVE ASSAY; RISK FACTOR; STANDARDIZATION;

CORNEA; CORNEAL NEOVASCULARIZATION; FEMALE; GERMANY; GRAFT REJECTION; HUMANS; INCIDENCE; KERATOPLASTY, PENETRATING; MALE; PHOTOGRAPHY; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 0034900024     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-16291     Document Type: Article

References (36)

1. Angiogenesis and ophthalmic disease
2. The pathogenesis of suture toxicity
3. Blood-vessel formation in the cornea
4. Mechanisms of angiogenesis and arteriogenesis
5. 1 in human corneas with neovascularization
6. Changing indications for penetrating keratoplasty: Histopathology of 1250 corneal buttons
7. Angiogenesis in corneal diseases: Histopathology of 254 human corneal buttons with neovascularization
8. Angiogenese und angiogenesehemmung im auge
9. Interleukin-1 receptor antagonist suppresses Langerhans' cell activity and promotes ocular immune privilege
10. Suture erosion after penetrating keratoplasty
11. Corneal neovascularization after penetrating keratoplasty
12. Loss and restoration of immune privilege in eyes with corneal neovascularization
13. Topical interleukin 1 receptor antagonist promotes corneal transplant survival
14. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis
15. Veränderungen an kunststoff-fäden nach langer verweildauer im hornhautgewebe
16. Immunolocalisation of thrombospondin 1 in human, bovine and rabbit cornea
17. Nahttechnik bei perforierender keratoplastik
18. Conjunctival transdifferentiation is due to the incomplete removal of limbal basal epithelium
19. Aqueous flare following penetrating keratoplasty and in corneal graft rejection
20. Design und erste ergebnisse der prospektiven "Erlanger Nicht-Hochrisiko-Keratoplastik-Studie"
21. Wandlungen in der indikationsstellung zur keratoplastik (Erlangen, 1964-1986)
22. Endostatin localization in the cornea
23. The stimulus to neovascularization in the cornea
24. Nonabsorbable suture material in corneoscleral sections-a comparison of novofil and nylon
25. Corneal transplantation in anterior segment diseases. The Bowman Lecture
26. Erlanger augenblätter
27. Effect of vascular endothelial growth factor and flt3 ligand on dendritic cell generation in vivo
28. Molecular cloning of a new angiopoetinlike factor from the human cornea
29. Topographisch-metrische beziehungen zwischen limbus corneae, kammerwinkel, Iris und Corpus ciliare. Ein beitrag zur "chirurgischen Anatomie"
30. Immunologische transplantatreaktion nach nichtmechanischer hornhauttrepanation mit dem excimerlaser
31. Hornhaut-dimensionen bei verschiedenen hornhautdystrophien und ihre bedeutung für die perforierende keratoplastik
32. Non-mechanical corneal trephination with the excimer laser improves outcome after penetrating keratoplasty
33. Suture removal
34. Regional immunity and ocular immune privilege
35. Immunobiology and immunopathology of corneal transplantation
36. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts